PMA device
Angio-Seal Vascular Closure Device
Terumo Medical Corporation · Device, Hemostasis, Vascular (MGB, Class III) · First FDA decision Mar 23, 2000, newest Apr 15, 2013Vascular access
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
7
PMA pathway
Device trials
12
Naming "Angio-Seal"
MAUDE reports
9,216
Brand "Angio-Seal", since 2015
PubMed studies
294
Mentioning "Angio-Seal"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Angio-Seal Vascular Closure Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 7 decisions filed under this name.
- ANGIO-SEAL VASCULAR CLOSURE DEVICEPMA supplement
P930038-S067 · Decided Apr 15, 2013 · 650 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, hemostasis, vascular (MGB) · Cardiology
- ANGIO-SEAL VASCULAR CLOSURE DEVICEPMA supplement
P930038-S052 · Decided Sep 26, 2008 · 273 days after receipt · Normal 180 Day Track
Device type: Device, hemostasis, vascular (MGB) · Cardiology
- ANGIO-SEAL VASCULAR CLOSURE DEVICEPMA supplement
P930038-S046 · Decided Oct 5, 2006 · 358 days after receipt · Normal 180 Day Track
Device type: Device, hemostasis, vascular (MGB) · Cardiology
3 more FDA decisions with a free account
Older decisions: P930038-S024
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Angio-Seal", any status and sponsor, newest update first.
- Comparing Suture vs. Combined Closure Strategies for Large Blood Vessel Access in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI)Pivotal-lookingNot yet recruiting
University Hospital, Basel, SwitzerlandAcademic, hospital or other
NCT07743697 · 705 participants (planned) · Start Oct 1, 2026 · Primary completion Sep 2028
Device: Single Suture-Based Vascular Closure Device; Extravascular Collagen Plug-Based Closure Device · For: Aortic Valve Stenosis; Postoperative Complications; Vascular System Injuries and 1 more
Sites: Basel, Switzerland
- Comparison of Different Vascular Closure Device in TAVIPivotal-lookingCompleted
National Taiwan University HospitalAcademic, hospital or other
NCT05491070 · 260 participants · Start Mar 20, 2018 · Primary completion Apr 13, 2023
Device: Vascular closure device (Angio-Seal, Progilde) · For: Aortic Valve Stenosis; Transcatheter Aortic Valve Implantation
Sites: Taipei, Taiwan
- Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve ImplantationPivotal-lookingCompleted
Deutsches Herzzentrum MuenchenAcademic, hospital or other
NCT05503199 · 450 participants · Start Oct 1, 2022 · Primary completion Apr 18, 2024
Device: Combination of one Perclose ProGlide or ProStyle (Abbott Vascular) and one Angio-Seal (Terumo).; Combination of two ProGlides or ProStyles (Abbott Vascular). · For: Aortic Valve Stenosis
Sites: Munich, Germany
9 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Angio-Seal", and for the whole product code for context.
This brand
9,216 reports: 4,251 malfunction, 4,918 injury, 43 death
Whole product code MGB
93,533 reports: 17,154 malfunction, 76,023 injury, 315 death
Newest reports for this brand
- ANGIO-SEALMalfunction
3013394970-2026-00625 · Received Oct 28, 2026 · Event dated Sep 29, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Activation Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- ANGIO-SEALMalfunction
3013394970-2026-00626 · Received Oct 28, 2026 · Event dated Sep 30, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Material Deformation
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- ANGIO-SEALMalfunction
3013394970-2026-00627 · Received Oct 28, 2026 · Event dated Sep 30, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Activation Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2337-2018 · Started Apr 9, 2018
Reason given: Two lots of product were released for distribution prior to the completion of all required validation and lot acceptance activities. Although sterile, products from these lots may not function as intended and therefore should not be used.
Cause as FDA categorized it: Release of Material/Component prior to receiving test results · Device type: Device, Hemostasis, Vascular (MGB)
St. Jude Medical / Daig Division
Z-0677-06 · Started Aug 22, 2005 · Posted by FDA Mar 25, 2006
Reason given: Mispackaging-Some Angio-Seal 6F STS Vascular Closure Devices from Lot no. 1146548 have been incorrectly packaged with a 0.035' guidewire instead of a 0.032' guidewire.
Cause as FDA categorized it: Other · Device type: Device, Hemostasis, Vascular (MGB)
Published research
The most relevant PubMed records for "Angio-Seal"[tiab]. The summary above synthesizes these.
- Ultrasound-guided angio-seal deployment.
Ravi R, Chan TY, Shaikh UH, et al. · J Vasc Interv Radiol · 2015Letter
- The Art of the Seal.
Arunothayaraj S, Palmer S, Whitbourn R · JACC Cardiovasc Interv · 2021
- Difficult Percutaneous Closure of Axillary Access.
Fong EYH, Chui ASF, Chan AKC, et al. · J Invasive Cardiol · 2022
- Percutaneous endovascular management of Angio-Seal related vascular occlusion.
Haberman D, Czulada E, Lupu L, et al. · Catheter Cardiovasc Interv · 2024
- Review of vascular closure devices.
Schwartz BG, Burstein S, Economides C, et al. · J Invasive Cardiol · 2010Research Support, Non-U.S. Gov't, Review
- Penoscrotal haematoma after cardiac catheterisation.
Kumar V, Soni P, Chadha S, et al. · BMJ Case Rep · 2017Case Reports
- A Peculiar Case of a Floating Angio-Seal.
Dettmers RC, Bosman WM, van den Broek MA, et al. · Open Cardiovasc Med J · 2016
- Angio-Seal Closure for Traumatic Left Subclavian Artery Pseudoaneurysm: A Case Report.
Moey MYY, Prabhudesai V, Greco E, et al. · J Soc Cardiovasc Angiogr Interv · 2024Case Reports
- Angio-Seal Used as a Bailout for Incomplete Hemostasis After Dual Perclose ProGlide Deployment in Transcatheter Aortic Valve Implantation.
Cakal B, Cakal S, Karaca O, et al. · Tex Heart Inst J · 2022
- Complications with the use of Angio-Seal vascular closure device and their management.
Shariq M, Premnath KPB, Saleh AT, et al. · J Clin Imaging Sci · 2023Case Reports
- Puncture site hemostasis.
Kensey KR · J Invasive Cardiol · 1994
- Angio-Seal for Right Ventricle Perforation During Pericardiocentesis for Cardiac Tamponade: A Case Report.
Aria S, Hlaing SH, Dautov R, et al. · J Soc Cardiovasc Angiogr Interv · 2025Case Reports
Other devices of this type
Also filed under product code MGB.
- Perclose ProGlide® Suture-Mediated Closure SystemAbbott Vascular, Inc. · PMA 2025
- StarClose SE® Vascular Surgical SystemAbbott Vascular Devices · PMA 2025
- Mynx Vascular Closure DeviceCordis US Corporation · PMA 2013
- MANTA Vascular Closure DeviceTeleflex Medical, LLC · PMA 2024
- Vascade Vascular Closure System (VCS)Cardiva Medical, Inc. · PMA 2023
- MynxGrip and Mynx Ace Vascular Closure DeviceCordis US Corporation · PMA 2018
- Vascular Solutions Duett Sealing DeviceVascular Solutions, Inc. · PMA 2010
- Angio-Seal Hemostatic Puncture Closure DeviceTerumo Medical Corporation · PMA 2000
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.